4.1 Article

Changes in the modulation of retinocollicular transmission through group III mGluRs long after an increase in intraocular pressure in a rat model of glaucoma

期刊

VISUAL NEUROSCIENCE
卷 29, 期 4-5, 页码 237-246

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0952523812000193

关键词

Superior colliculus; Rodent visual system; Retinal ganglion cell; Metabotropic glutamate receptors; Synaptic transmission

资金

  1. Medical Research Council (UK)
  2. Wellcome Trust

向作者/读者索取更多资源

Metabotropic glutamate receptors (mGluRs) have been shown to be involved in the modulation of retinocollicular neurotransmission. In glaucoma, retinal ganglion cells (RGCs) degenerate, which may have an implication on this transmission as the superior colliculus is their major central target in the much-used rodent models of the disease. We have investigated this using an in vitro slice preparation of the superior colliculus by eliciting field excitatory postsynaptic potentials (fEPSPs) through optic tract stimulation in a rat ocular hypertension model of glaucoma. Application of the group III mGluR agonist L-AP4 reduced the peak amplitude of the tEPSP in superior colliculus slices through presynaptic mechanisms as previously shown in our lab. At 3 and 16 weeks after surgery, there were no significant differences in the effect of L-AP4 on fEPSP peak amplitude in the superior colliculus slices receiving input from the glaucomatous eyes [elevated intraocular pressure (IOP)] compared to those with input from the unoperated eyes (normal IOP). However, at 32 weeks, the fEPSP peak amplitude was reduced to a significantly greater degree during L-AP4 application in the elevated IOP slices compared to normal IOP slices. At all time points, there were no significant changes in the baseline amplitudes of fEPSPs or the stimulus intensities required to evoke fEPSPs. These results suggest that the modulation of synaptic transmission through group III mGluRs on RGC terminals to the superior colliculus is changed at later stages due to RGC degeneration through IOP elevation. These changes may be compensatory changes possibly through plasticity in the RGC terminals of surviving cells, which may be due to increases in the numbers of group III mGluRs. This result may have implications on further treatment studies carried out using these models of glaucoma as changes in the central visual system may need to be considered along with the retinal changes that occur.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Ophthalmology

Comparison of preserved bimatoprost 0.01% with preservative-free tafluprost: A randomised, investigator-masked, 3-month crossover, multicentre trial, SPORT II

Sophie Lemmens, Luca Rossetti, Francesco Oddone, Gordana Sunaric-Megevand, Anton Hommer, Evelien Vandewalle, Maria Francesca Cordeiro, Andrew McNaught, Giovanni Montesano, Ingeborg Stalmans

Summary: This study showed that bimatoprost significantly reduced intraocular pressure compared to tafluprost with minimal difference in side effects. The findings are important for considering the pros and cons of preserved versus preservative-free prostaglandin analogue therapy.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2022)

Review Ophthalmology

Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic

Maria Francesca Cordeiro, Daniel Hill, Radhika Patel, Paolo Corazza, John Maddison, Saad Younis

Summary: DARC is a retinal imaging technology that uses ANX776 to identify stressed and apoptotic cells. It has the potential to be used as a biomarker, but further large-scale studies are needed to validate its diagnostic value.

PROGRESS IN RETINAL AND EYE RESEARCH (2022)

Meeting Abstract Ophthalmology

VSN16S, an agonist of the cannabinoid receptor, reduces IOP profiles and exhibits neuroprotective properties in a rat model of glaucoma

Li Guo, Vy Luong, Aaron Gregson, David Baker, David Selwood, M. Francesca Cordeiro

ACTA OPHTHALMOLOGICA (2022)

Article Biophysics

Measures of disease activity in glaucoma

Yue Wu, Maja Szymanska, Yubing Hu, M. Ihsan Fazal, Nan Jiang, Ali K. Yetisen, M. Francesca Cordeiro

Summary: Glaucoma is the leading cause of irreversible blindness globally, emphasizing the importance of early detection and diagnosis. Early detection of glaucoma can prevent deterioration of vision and quality of life.

BIOSENSORS & BIOELECTRONICS (2022)

Article Multidisciplinary Sciences

Automated characterisation of microglia in ageing mice using image processing and supervised machine learning algorithms

Soyoung Choi, Daniel Hill, Li Guo, Richard Nicholas, Dimitrios Papadopoulos, Maria Francesca Cordeiro

Summary: A machine learning approach was developed to automatically classify images of retinal microglial cells. The study found that the morphology and density of microglia undergo significant changes in health, senescence, and disease, suggesting their dynamic role in the ageing process.

SCIENTIFIC REPORTS (2022)

Review Neurosciences

Microglia: Key Players in Retinal Ageing and Neurodegeneration

Li Guo, Soyoung Choi, Priyanka Bikkannavar, M. Francesca Cordeiro

Summary: Microglia, as resident immune cells in the central nervous system, play a crucial role in maintaining the normal function of the retina and brain. They can be activated to protect neurons and tissue integrity, but their functions and phagocytic capacity may decline with aging, leading to neuroinflammation and neurodegenerative diseases.

FRONTIERS IN CELLULAR NEUROSCIENCE (2022)

Review Ophthalmology

How latanoprost changed glaucoma management

Maria Francesca Cordeiro, Stefano Gandolfi, Konstantin Gugleta, Eduardo M. Normando, Francesco Oddone

Summary: Glaucoma is a major cause of visual impairment and blindness worldwide. Prostaglandin analogues (PGAs), introduced 25 years ago, have become the first-choice treatment for primary open-angle glaucoma due to their efficacy, limited side effects, and once daily dosing. However, they are associated with mild to moderate ocular and periocular adverse events.

ACTA OPHTHALMOLOGICA (2023)

Article Ophthalmology

Effects of COVID-19 pandemic on glaucoma appointment scheduling in a tertiary hospital in London, UK

Barbara Burgos-Blasco, Beatriz Vidal-Villegas, Timothy E. Yap, Eduardo M. Normando, Sally Ameen, Laura Crawley, Faisal Ahmed, Philip A. Bloom, M. Francesca Cordeiro

Summary: The purpose of this study was to investigate the impact of the COVID-19 pandemic and the triage system on the glaucomatous disease of patients in a London tertiary hospital. A total of 200 glaucoma patients with delayed appointments were included in this observational retrospective study. The results showed that the delayed care had a negative impact on the glaucomatous disease of patients, resulting in a third of the patients needing to change their treatment or undergo surgery.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2023)

Review Pathology

Detection of macular atrophy in age-related macular degeneration aided by artificial intelligence

Wei Wei, Rajeevan Anantharanjit, Radhika Pooja Patel, Maria Francesca Cordeiro

Summary: Age-related macular degeneration (AMD) is a leading cause of irreversible visual impairment worldwide. The permanent loss of the RPE and overlying photoreceptors characterizes macular atrophy (MA) in both dry and wet forms of AMD. Artificial Intelligence (AI) combined with ophthalmic imaging modalities, particularly OCT, has shown great promise in the early detection of MA.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2023)

Article Multidisciplinary Sciences

Deep learning to detect macular atrophy in wet age-related macular degeneration using optical coherence tomography

Wei Wei, Joshua Southern, Kexuan Zhu, Yefeng Li, Maria Francesca Cordeiro, Kirill Veselkov

Summary: In this study, a deep learning method using optical coherence tomography (OCT) analysis was developed to automatically detect and quantify six main clinically relevant atrophic features associated with macular atrophy (MA) in patients with wet age-related macular degeneration (AMD). The method achieved high accuracy and sensitivity in predicting these features, making it valuable for early diagnosis and identification of MA progression in wet AMD patients.

SCIENTIFIC REPORTS (2023)

Article Clinical Neurology

A proposed theoretical framework for retinal biomarkers

Ian James Callum MacCormick, Bo Zhang, Daniel Hill, Maria Francesca Cordeiro, Dylan S. S. Small

Summary: This study proposes a theoretical framework for retinal biomarkers of Alzheimer's disease (AD) based on Bayesian network analysis. It highlights the importance of recognizing inferential assumptions and provides a visual approach to assess the relationship between retinal and brain changes. The framework can help improve the discovery and validation of biomarkers for AD.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2022)

Meeting Abstract Ophthalmology

Glaucoma rose plots: redesigning circumpapillary progression analysis

Timothy Edward Yap, Benjamin Davis, Philip Bloom, Maria Francesca Cordeiro, Eduardo Normando

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2022)

Meeting Abstract Ophthalmology

Characterising DARC (Detecting Apoptosing Retinal Cells) spots in glaucoma and healthy eyes

John Maddison, Soyoung Choi, M. Francesca Cordeiro

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2022)

Article Biochemical Research Methods

Quantitative brain-derived neurotrophic factor lateral flow assay for point-of-care detection of glaucoma

Yue Wu, Yubing Hu, Nan Jiang, Rajeevan Anantharanjit, Ali K. Yetisen, M. Francesca Cordeiro

Summary: Glaucoma, a leading cause of irreversible blindness, requires accurate and timely diagnosis. This study developed a portable glaucoma detection method based on lateral flow assay to measure BDNF concentration in tears. The method showed high selectivity and stability and can be used for on-site testing.

LAB ON A CHIP (2022)

Review Pharmacology & Pharmacy

Accelerating precision ophthalmology: recent advances

Loay Rahman, Ammaarah Hafejee, Rajeevan Anantharanjit, Wei Wei, Maria Francesca Cordeiro

Summary: Precision medicine is the future of ophthalmology, offering improved diagnosis and treatment through the application of technology. Artificial intelligence and deep learning are key tools in advancing precision medicine in ocular diseases. Challenges include optimizing training sets for algorithms and further developing pharmacogenetics.

EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT (2022)

暂无数据